Astrantus’s CVS Health CVS Stock Holding History

Astrantus’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$388K	Sell	3,836 -10,464	-73%	-$1.1M	0.65%	60
2021 Q4	$1.48M	Buy	+14,300	New	+$1.32M	1.1%	3

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Astrantus's CVS Position: Q1 2022 in Review

Astrantus reduced its CVS Health (CVS) stake by 73% in Q1 2022, selling an estimated $1.1M and leaving 3,836 shares worth $388K. The position accounts for 0.65% of the portfolio, ranked #60.

Astrantus first reported a position in CVS in Q4 2021 and has held it in 2 quarters since. The position peaked at $1.48M in Q4 2021. 2,366 funds tracked by Wall St. Rank hold CVS as of Q1 2022.

Astrantus held 3,836 shares of CVS Health worth $388K as of Q1 2022.
Astrantus sold 10,464 CVS Health shares in Q1 2022, an estimated $1.1M.
CVS Health made up 0.65% of Astrantus's portfolio in Q1 2022, its #60 holding.
Astrantus first reported a position in CVS Health in Q4 2021 and has held it in 2 quarters since.
Astrantus's CVS Health position peaked at $1.48M in Q4 2021.
2,366 funds tracked by Wall St. Rank held CVS Health as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.